Request a callback or speak to admissions if you want help choosing between online theory, VTCT study and hands-on training
Compounded versions of semaglutide are not FDA approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy
In the Phase 3 REDEFINE 1 trial, CagriSema produced a mean body weight reduction of approximately 22.7% from baseline at 68 weeks in adults with obesity (without type 2 diabetes)
Ali K, et al
Pregnant women or those planning to become pregnant should discuss with their health care provider before starting either of these medications
Common Side Effects: - Nausea, diarrhea, vomiting, decreased appetite, dyspepsia, and constipation